Dipna Pharmachem informs about outcome of board meeting

29 Nov 2025 Evaluate
With reference to the Board Meeting held on 9th September, 2025 and 12th September, 2025 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dipna Pharmachem has informed that the Board of Directors of the Company, at its meeting held today, i.e., Saturday, 29th November, 2025, at the registered office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India - 380 055, which commenced at 11:30 AM and concluded at 12:10 PM, have considered and approved the allotment of 22,44,000 fully Paid-up Equity Shares pursuant to conversion of 22,44,000 convertible warrants (Out of a total 5,80,32,500 Convertible Warrants) having a face value of Rs 10.00 each, at an issue price of Rs 13.05 each (including premium of Rs 03.05 each), on receipt of the balance amount, i.e., 75.00% of the issue price per warrant, from Ashok Dilipkumar Jain and Kajal Ashok Jain, the allottee(s) belonging to the ‘Non-Promoter Category’, upon exercise of option to convert the Warrants into Equity Shares in accordance with the provisions of SEBI (ICDR) Regulations, 2018. Details of allotment as mentioned in Annexure - I. The allotment has been made for cash, upon receipt of the remaining exercise price of Rs. 9.79 each (being an amount equivalent to 75.00% of the warrant exercise price of Rs 13.05 each), aggregating to Rs 2,19,63,150.00. The Equity Shares allotted upon the exercise of warrants on a preferential basis shall rank pari-passu with the existing equity shares of the Company in all respects. Consequent to the aforesaid conversion, the paid-up equity share capital of the Company has increased from Rs 24,04,52,500.00 consisting of 2,40,45,250 equity shares having face value of Rs 10.00 each to Rs. 26,28,92,500.00 consisting of 2,62,89,250 Equity Shares having face value of Rs 10.00 each. The application for listing and trading approval of the newly issued and allotted equity shares will be made to the Stock Exchange in due course. Further, the requisite information regarding the issuance of securities under Regulation 30 of SEBI (LODR) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 as mentioned in Annexure - II.

The above information is a part of company’s filings submitted to BSE.

Dipna Pharma. Share Price

15.00 -0.99 (-6.19%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Redington 268.50
Adani Enterprises 2265.10
Amrapali Industries 15.02
Rashi Peripheral 325.05
PDS 339.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×